Ciz1 is associated with tumor growth in small cell (SCLC) and non-small cell lung carcinoma (NSCLC) [73], colorectal [74,75], breast [76,77], prostate [78], hepatocellular carcinoma [79] and gall bladder cancer [80]. Here, CIZ1 is linked to non-small cell lung carcinoma.